| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |